CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancerMasaaki Takai, Masahide Ohmichi, Yoshito Terai et al.|Journal of Ovarian Research|2014Cited by 108
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancerKazuya Maeda, Masahide Ohmichi, Shinichi Terada et al.|Journal of Ovarian Research|2020Cited by 59
The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dyeTomohito Tanaka, Masahide Ohmichi, Yoshito Terai et al.|Journal of Gynecologic Oncology|2016Cited by 38
Associations between the pre‐pregnancy body mass index and gestational weight gain with pregnancy outcomes in <scp>J</scp>apanese womenTomohito Tanaka, Masahide Ohmichi, K Ashihara et al.|Journal of obstetrics and gynaecology research|2014Cited by 34